Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Hong Kong Morning Sun.
Press releases published on June 2, 2025
MOIN Launches Cross-Border Remittance Service via Toss App, Enhancing Accessibility for 28 Million Users
EIN Presswire
·
June 2, 2025
MOIN, a leading fintech company specializing in cross-border remittance solutions, has launched its cross-border money transfer service on Toss SEOUL, EUNPYEONG, SOUTH KOREA, June 2, 2025 /EINPresswire.com/ -- MOIN, a leading fintech company …
BexBack Launches Double Deposit Bonus, $50 Welcome Bonus and 100x Leverage Crypto Trading No KYC
GlobeNewswire
·
June 2, 2025
SINGAPORE, June 02, 2025 (GLOBE NEWSWIRE) -- As the price of Bitcoin surpassed the $100,000 mark and subsequently stabilized above $100,000, many analysts believe that it will enter a long-term high-volatility market. Holding spot positions may not …
Pitanium Limited Announces Closing of Initial Public Offering
GlobeNewswire
·
June 2, 2025
HONG KONG, June 02, 2025 (GLOBE NEWSWIRE) -- Pitanium Limited (Nasdaq: PTNM) (“Pitanium” or the “Company”), a company that retails its proprietary brand focusing on beauty and personal care products, announced today that it closed its initial public …
G2A.COM introduces G2A Plus Free, a new package for its loyalty program
GlobeNewswire
·
June 2, 2025
AMSTERDAM, June 02, 2025 (GLOBE NEWSWIRE) -- Launched in 2017, G2A Plus is a loyalty program designed to enhance the shopping experience for buyers while supporting sellers in driving repeat purchases. Over the years it has provided real value across …
NewGen Announces Planned $30 Million Strategic Investment in Solana Digital Asset Staking
GlobeNewswire
·
June 2, 2025
BANGKOK, June 02, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced plans …
HUTCHMED Highlights SACHI Phase III Study Data Presented at the 2025 ASCO Annual Meeting
GlobeNewswire
·
June 2, 2025
— The all-oral chemotherapy-free combination of savolitinib plus osimertinib demonstrated significant PFS benefit with a favorable safety profile in the SACHI Phase III China study — — Webcast to be held at 8:30 am HKT on Tuesday, June 3 to discuss the …